WooGeneB&G KRX:018620KOSDAQ
우진비앤지 · Korean news coverage and regulatory filings, organized.
Articles, 24h1
Articles, 7 days1
DART filings, 7 days0
Articles tracked1since Sep 11
In Q2 2026, WooGeneB&G reported revenue of ₩15.5bn, up 12.7% year on year, and operating profit of ₩1.4bn. WooGeneB&G (우진비앤지) appeared in 1 Korean news article and 0 DART filings over the past seven days. Coverage peaked on Oct 30 with 1 article. It was most often mentioned alongside Sajo Industries.
Filing signals Insider buying Major holder adding Screener
WooGeneB&G quarterly results consolidated, KRW
| Quarter | Revenue | YoY | Operating profit | Net income |
|---|---|---|---|---|
| Q2 2026 | ₩15.5bn | +12.7% | ₩1.4bn margin 8.9% | ₩1.5bn |
| Q1 2026 | ₩14.3bn | -0.1% | ₩705m margin 4.9% | −₩158m |
| Q4 2025 derived | ₩13.5bn | -0.1% | ₩459m margin 3.4% | −₩3.5bn |
| Q3 2025 | ₩13.2bn | +13.1% | −₩769m margin −5.8% | −₩1.3bn |
| Q2 2025 | ₩13.7bn | -4.8% | ₩206m margin 1.5% | ₩1.0bn |
| Q1 2025 | ₩14.3bn | -10.9% | ₩424m margin 3.0% | ₩148m |
| Q4 2024 derived | ₩13.5bn | -18.0% | −₩1.1bn margin −8.3% | −₩6.9bn |
| Q3 2024 | ₩11.7bn | -10.1% | −₩126m margin −1.1% | −₩405m |
Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases. Margin is operating profit divided by revenue — see operating margin.
WooGeneB&G top stories 2 weeks, by number of outlets
- 1